Data di Pubblicazione:
2020
Abstract:
This commentary article conveys the views of the board of the Nanomedicine and Nanoscale Delivery Focus Group of the Controlled Release Society regarding the decision of the United States National Cancer Institute (NCI) in halting funding for the Centers of Cancer Nanotechnology Excellence (CCNEs), and the subsequent editorial articles that broadened this discussion.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
Cancer therapy; Clinical translation; Nanomedicine; Nanotechnology; Reproducibility
Elenco autori:
Martins, Jp; das Neves, J; de la Fuente, M; Celia, C; Florindo, H; Günday-Türeli, N; Popat, A; Santos, Jl; Sousa, F; Schmid, R; Wolfram, J; Sarmento, B; Santos, Ha.
Link alla scheda completa:
Link al Full Text:
Pubblicato in: